DebasishTripathyMD

PubMed

• Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
  Elias, A., Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, A Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M Wallace, Henry Kapla...> ;Clinical Cancer Research. 2024 Feb 16
• Real-World Experience in Hispanic Patients With Breast Cancer and Brain Metastases Using Different Prognostic Tools.
  Bernardo Cacho-Díaz, Debu Tripathy, Victor A Arrieta, Angel Escamilla-Ramirez, Alberto Alvarado-Miranda, Oscar Rodríguez-Mayoral> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Feb 15
• 1 citations
  Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic Therapy.
  Musall, B., Rauch, D., Mohamed, R., Panthi, B., Boge, M., Candelaria, R., Chen, H., Guirguis, M., Hunt, K., Huo, L., Hwang, K., Korkut, A., Litton, J., Moseley, T., Pa...> ;Journal of Magnetic Resonance Imaging. 2024 Jan 31
• Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics.
  Adesoye, T., Keyomarsi, K., Tripathy, D., Hunt, K.> ;Cancers. 2024 Jan 24
• 1 citations
  LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells.
  Kumar, D., Gurrapu, S., Wang, Y., Bae, S., Pandey, P., Chen, H., Mondal, J., Han, H., Wu, C., Karaiskos, S., Yang, F., Sahin, A., Wistuba, I., Gao, J., Tripathy, D., G...> ;Nature Cancer. 2024 Feb 1
• Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma.
  Qaio, W., Shen, Y., Raghavendra, A., Mouabbi, J., Tripathy, D., Layman, R.> ;The Oncologist. 2024 Mar 4
• Measures of functional status in older patients treated with palbociclib for advanced breast cancer.
  Cappelleri, J., Cuevas, J., Montelongo, M., Wang, Y., Karuturi, M., Blum, J., Patel, K., Telivala, B., McCune, S., Lakhanpal, S., Tripathy, D., Rocque, G.> ;Journal of Geriatric Oncology. 2024 Jan 1
• Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
  Beverly Kyalwazi, Christina Yau, Michael J Campbell, Toshio F Yoshimatsu, A Jo Chien, Anne M Wallace, Andres Forero-Torres, Lajos Pusztai, Erin D Ellis, Kathy S Albain...> ;JAMA Network Open. 2023 Dec 1
• Outcomes of male patients with HR+/HER2- advanced breast cancer receiving palbociclib in the real-world POLARIS study.
  Joanne L Blum, Caroline DiCristo, David Gordon, Meghan S Karuturi, David Oubre, Erin Jepsen, Juan Cuevas, Shailendra Lakhanpal, Monica Z Montelongo, Zhe Zhang, Joseph ...> ;Breast Cancer Research and Treatment. 2024 Feb 1
• Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer.
  Zhan Xu, David E Rauch, Rania M Mohamed, Sanaz Pashapoor, Zijian Zhou, Bikash Panthi, Jong Bum Son, Ken-Pin Hwang, Benjamin C Musall, Beatriz E Adrada, Rosalind P Cand...> ;Cancers. 2023 Oct 2
• Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency.
  Shane R Stecklein, William Barlow, Lajos Pusztai, Kirsten Timms, Richard Kennedy, Gemma E Logan, Rob Seitz, Sunil Badve, Yesim Gökmen-Polar, Peggy Porter, Hannah Linde...> ;JCO Precision Oncology. 2023 Sep 1
• 1 citations
  Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospecti...
  Nour Abuhadra, Ryan Sun, Clinton Yam, Gaiane M Rauch, Qingqing Ding, Bora Lim, Alastair M Thompson, Elizabeth A Mittendorf, Beatriz E Adrada, Senthil Damodaran, Kiran ...> ;Cancers. 2023 Jun 21
• 10 citations
  Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
  Mark Jesus M Magbanua, Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W Sayaman, Derrick Renner, Ekaterina Kalashnikova, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen...> ;Cancer Cell. 2023 Jun 12
• 2 citations
  A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer.
  Clinton Yam, Elizabeth A Mittendorf, Haven R Garber, Ryan Sun, Senthil Damodaran, Rashmi K Murthy, David Ramirez, Meghan Karuturi, Rachel M Layman, Nuhad Ibrahim, Gaia...> ;Breast Cancer Research and Treatment. 2023 Jun 1
• Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy.
  Nour Abuhadra, Ryan Sun, Roland L Bassett Jr, Lei Huo, Jeffrey T Chang, Mediget Teshome, Alyson R Clayborn, Jason B White, Elizabeth E Ravenberg, Beatriz E Adrada, Ros...> ;Investigational New Drugs. 2023 Jun 1
• Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer.
  Blessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, Neeta Somaiah, Sarina Piha-Paul, Julia Ann Moore, Bulent Yilmaz, Deby Ogbonna, Daniel D Karp, Ecaterina Dumb...> ;Cancer. 2023 Jul 15
• Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines.
  Xuemei Xie, Jangsoon Lee, Jon A Fuson, Huey Liu, Toshiaki Iwase, Kyuson Yun, Cori Margain, Debu Tripathy, Naoto T Ueno> ;Biomedicines. 2023 Feb 28
• Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer.
  Bikash Panthi, Rania M Mohamed, Beatriz E Adrada, Medine Boge, Rosalind P Candelaria, Huiqin Chen, Kelly K Hunt, Lei Huo, Ken-Pin Hwang, Anil Korkut, Deanna L Lane, Hu...> ;Frontiers in Oncology. 2023 Jan 1
• 25 citations
  Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.
  Jason A Mouabbi, Amy Hassan, Bora Lim, Gabriel N Hortobagyi, Debasish Tripathy, Rachel M Layman> ;Breast Cancer Research and Treatment. 2022 Jun 1
• 2 citations
  Oral Oncolytics: Using Remote Technology to Improve Access, Operational Efficiency, and Satisfaction.
  Abbey Kaler, Victoria McClosky, Akshara S Raghavendra, Debasish Tripathy> ;Clinical Journal of Oncology Nursing. 2022 Jun 1
• 264 citations
  21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
  Kevin Kalinsky, William E. Barlow, Julie R. Gralow, Funda Meric-Bernstam, Kathy S. Albain, Daniel F. Hayes, Nan Lin, Edith A. Perez, Lori J. Goldstein, Stephen Chia, S...> ;The New England Journal of Medicine. 2021 Dec 1
• 4 citations
  A randomized trial of fulvestrant, everolimus and anastrozole for the front-line treatment of patients with advanced hormone receptor-positive breast cancer, SWOG S1222.
  Halle C. F. Moore, William E. Barlow, George Somlo, Julie R. Gralow, Anne F. Schott, Daniel F. Hayes, Peter Kuhn, James W. Hicks, Lisa Welter, Philip A. Dy, Christina ...> ;Clinical Cancer Research. 2021 Nov 29
• 22 citations
  Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells.
  Stanley Ly, Vivek Anand, Fouad El-Dana, Khoa Nguyen, Yiming Cai, Shirong Cai, Helen Piwnica-Worms, Debasish Tripathy, Aysegul A Sahin, Michael Andreeff, Venkata Lokesh...> ;Journal for Immunotherapy of Cancer. 2021 Mar 1
• 1 citations
  Validation of plasma metabolites associated with breast cancer risk among Mexican Americans.
  Hua Zhao, Jie Shen, Yuanqing Ye, Xifeng Wu, Francisco J. Esteva, Debasish Tripathy, Wong Ho Chow> ;Cancer Epidemiology. 2020 Sep 30
• 99 citations
  Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Can...
  Douglas Yee, Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans, Kathy S. Albain, Yunn Yi Chen, Gregor Krings, Shi Wei, Shuko Harada, Brian Datnow, Ol...> ;JAMA Oncology. 2020 Sep 1
• Join now to see all

Lectures

• ATTAIN: Phase 3 study of etirinotecan pegol (EP) vs. treatment of physician's choice (TPC) in patients (pts) with metastatic breast cancer (MBC) who have stable brain ... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018